Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon S Imber

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Journal of Neuro-Oncology|May 18, 2026
Care pathways for asymptomatic brain metastases: comparison of healthcare utilization, costs, and outcomes in outpatient versus acute settingsMatthew Wierzbicki, Stephen G Bowden, Stephanie M Robert, et al.
Journal of Neuro-Oncology|May 29, 2023
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CTLily A McLaughlin, Onur Yildirim, Marc K Rosenblum, et al.
Urology|September 17, 2022
Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage RadiationBrandon S Imber, Elisabeth O'Dwyer, Stephanie Lobaugh, et al.
Journal of Neuro-Oncology|July 27, 2022
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of Neuro-Oncology|August 23, 2022
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of the Endocrine Society|September 19, 2019
Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough?Brandon S Imber, Andrew L Lin, Zhigang Zhang, et al.
British Journal of Haematology|March 6, 2020
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapyBrandon S Imber, Michel Sadelain, Carl DeSelm, et al.
Frontiers in Oncology|April 15, 2025
Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approachKathryn R Tringale, Brandon S Imber, Gustav Y Cederquist, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2024
Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System LymphomaKathryn R Tringale, Christian Grommes, Burcin A Ucpinar, et al.
Journal of Neuro-Oncology|November 11, 2025
Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosisAllison J Toth, Stephanie M Robert, Tara Fahy, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Journal of Neuro-Oncology|May 18, 2026
Care pathways for asymptomatic brain metastases: comparison of healthcare utilization, costs, and outcomes in outpatient versus acute settingsMatthew Wierzbicki, Stephen G Bowden, Stephanie M Robert, et al.
Journal of Neuro-Oncology|May 29, 2023
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CTLily A McLaughlin, Onur Yildirim, Marc K Rosenblum, et al.
Urology|September 17, 2022
Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage RadiationBrandon S Imber, Elisabeth O'Dwyer, Stephanie Lobaugh, et al.
Journal of Neuro-Oncology|July 27, 2022
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of Neuro-Oncology|August 23, 2022
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of the Endocrine Society|September 19, 2019
Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough?Brandon S Imber, Andrew L Lin, Zhigang Zhang, et al.
British Journal of Haematology|March 6, 2020
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapyBrandon S Imber, Michel Sadelain, Carl DeSelm, et al.
Frontiers in Oncology|April 15, 2025
Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approachKathryn R Tringale, Brandon S Imber, Gustav Y Cederquist, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2024
Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System LymphomaKathryn R Tringale, Christian Grommes, Burcin A Ucpinar, et al.
Journal of Neuro-Oncology|November 11, 2025
Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosisAllison J Toth, Stephanie M Robert, Tara Fahy, et al.
Pageof 10